🇺🇸 FDA
Patent

US 12318364

Isoflavonoid compositions and methods for the treatment of cancer

granted A61KA61K31/337A61K31/353

Quick answer

US patent 12318364 (Isoflavonoid compositions and methods for the treatment of cancer) held by Aardvark Therapeutics, Inc. expires Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Aardvark Therapeutics, Inc.
Grant date
Tue Jun 03 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 29 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/337, A61K31/353, A61K31/555, A61K33/243